Condition: Preterm · Apnea of Prematurity · Hypoxemia · Sponsor: Pontificia Universidad Catolica de Chile
The goal of this clinical trial is to learn if the use of PIMUN(medical device) works to reduce the intermittent hypoxemia of 24-34 weeks of birth gestational age babies. . It will also learn about the safety of the use of PIMUN. The main questions it aims to answer are: Does PIMUN lower the time of oxygen saturation under 90%? What medical problems do participants have using PIMUN? Researchers will compare the use of PIMUN during 48 hours to 48 hours of usual treatments (not using PIMUN). Participants will: Use/ or not use of PIMUN for a 48 hours period- randomly assigned. Regional brain oxygenation by near infrared spectroscopy (NIRS) monitoring at the first day of each 48 hours period. 4-6 hours of polysomnography at the second day of each intervention. Plasma and urine stress oxygen metabolites at the end of each 48-hours intervention.
This description comes directly from the study's public registry record.
Paulina A Toso, MD · 56223543349 · ptoso@med.puc.cl
Alvaro J González, MD · 56223543224 · alvgonza@med.puc.cl
Always discuss trial participation with your own doctor first.
| Clinica San Carlos de Apoquindo | Santiago, Santiago Metropolitan, Chile | Active Not Recruiting |
| UC Christus Clinical Hospital | Santiago, Santiago Metropolitan, Chile | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07396103